Bromocriptine
Links shared publicly online about this topic
Bromocriptine, dopamine and glaucoma. -- Turner 62 (731): 819 -- Postgraduate Medical Journal
pmj.bmj.com — “Bromocriptine, dopamine and glaucoma. -- Turner 62 (731): 819 -- Postgraduate Medical Journal” View full resource at pmj.bmj.com
Most Recently Shared on October 29, 2009 at 4:27 am By:
@cairo_doc Wow! Didn't know bromocriptine could decrease IOP. http://bit.ly/1E69g1
Access : Pituitary tumors: Cabergoline versus bromocriptine: a meta-analysis? : Nature Reviews Endocrinology
nature.com — “Access : Pituitary tumors: Cabergoline versus bromocriptine: a meta-analysis? : Nature Reviews Endocrinology” View full resource at nature.com
Most Recently Shared on February 22, 2011 at 4:15 pm By:
Now AOP! Pituitary tumors: Cabergoline versus bromocriptine: a meta-analysis? by ME Molitch Professor @NUFeinbergMed http://ow.ly/414CM
Why does quick-release bromocriptine decrease cardiac events? - Bell - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Why does quick-release bromocriptine decrease cardiac events? - Bell - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on May 15, 2011 at 8:57 pm By:
Why does quickâ€*release bromocriptine decrease cardiac events?: A placebo controlled prospective safety study o... http://bit.ly/kwSWX6
Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study -- Sliwa et al. 121 (13): 1465 -- Circulation
circ.ahajournals.org — “Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study -- Sliwa et al. 121 (13): 1465 -- Circulation” View full resource at circ.ahajournals.org
Most Recently Shared on April 5, 2010 at 10:01 pm By:
Bromocriptine for peripartum cardiomyopathy - http://bit.ly/9SMiQW
Journal of Medical Case Reports | Full text | Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
jmedicalcasereports.com — “Journal of Medical Case Reports | Full text | Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports” View full resource at jmedicalcasereports.com
Most Recently Shared on March 5, 2010 at 4:01 pm By:
#JMCR, 'Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings' http://bit.ly/ciCgEP #casereport
Cardiology Medical News about Cardiomyopathies
mdlinx.com — “Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy. A Proof-of-Concept Pilot Study” View full resource at mdlinx.com
Most Recently Shared on March 24, 2010 at 7:58 am By:
Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy. A Proof-of-... http://bit.ly/9PUhAM #cardio #mdlinx
Cycloset available for type 2 diabetes - MPR
empr.com — “Santarus announced that Cycloset (bromocriptine mesylate tablets), a dopamine receptor agonist, has been made available for the management of type 2 diabetes as an adjunct to diet and exercise.” View full resource at empr.com
Most Recently Shared on November 16, 2010 at 2:54 pm By:
MPR News: Cycloset available for type 2 diabetes: Santarus announced that Cycloset (bromocriptine mesylate table... http://bit.ly/9SLZks
Cycloset Approved for Type 2 Diabetes - Health News - Health.com
news.health.com — “Cycloset (bromocriptine), a drug that takes the novel approach of managing blood sugar via the brain, has been approved by the U.S. Food and Drug Administration, maker VeroScience Inc. said Wednesday.” View full resource at news.health.com
Most Recently Shared on May 8, 2009 at 12:34 am By:
Cycloset Approved for Type 2 Diabetes: Cycloset (bromocriptine), a drug that takes the novel approach of managin.. http://tinyurl.com/dm54c7
CYCLOSET - New Product Releases - MPR
empr.com — “Adjunct to diet and exercise, to improve glycemic control in type 2 diabetes.” View full resource at empr.com
Most Recently Shared on December 10, 2010 at 3:02 pm By:
MPR News: CYCLOSET: Bromocriptine (as mesylate) 0.8mg; tabs. http://bit.ly/dFlX1I
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET | Business Wire
businesswire.com — “Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today announced the commercial U.S. launch of CYCLOSET® (bromocriptine mesyl” View full resource at businesswire.com
Most Recently Shared on November 16, 2010 at 1:57 pm By:
New diabetes drug enters market: Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET http://bit.ly/cjSjV4
Cycloset available for type 2 diabetes - ONA
oncologynurseadvisor.com — “Santarus announced that Cycloset (bromocriptine mesylate tablets), a dopamine receptor agonist, has been made available for the management of type 2 diabetes as an adjunct to diet and exercise.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 16, 2010 at 2:59 pm By:
Could my pituitary tumor have made me stop menstruating?
healthtap.com — “There is a tumor of the Pituitary gland called a Prolactinoma which can cause people to stop having periods. It is important to have this evaluated by a physician. It can be treated with a medication called Bromocriptine.” View full resource at healthtap.com
Most Recently Shared on September 7, 2011 at 2:09 am By:
#HealthTap: Could my pituitary tumor have made me stop menstruating? Answer http://t.co/e6ElyNT
Novel Diabetes Drug Cycloset Approved :: Diabetes Self-Management
diabetesselfmanagement.com — “Last week, the u.s. food and drug administration (fda) approved a new drug for treating type 2 diabetes. called cycloset, the drug is actually a new version of the older drug bromocriptine, which has been used at higher doses to treat people with parkinson disease.” View full resource at diabetesselfmanagement.com
Most Recently Shared on May 17, 2009 at 6:58 pm By:
Novel Diabetes Drug Cycloset Approved - http://tinyurl.com/pmspbp
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
medicalnewstoday.com — “Santarus, Inc. (NASDAQ: SNTS), S2 Therapeutics, Inc. and VeroScience LLC today announced that they have entered into a distribution and license agreement granting Santarus exclusive rights to manu” View full resource at medicalnewstoday.com
Most Recently Shared on September 10, 2010 at 5:00 pm By:
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET http://mnt.to/3JxK #diabetes
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Dr Robert Schertzer
Glaucoma specialist, EMR and tech guy, host 'Talking About Glaucoma' podcast
-
NatureRevEndocrinol
The latest research and clinical advances in diabetes, obesity, nutrition, thyroid and more from Nature Reviews Endocrinology, a clinical review journal
-
Diabetes, Type 2
Organizing type 2 diabetes resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

